viernes, 13 de noviembre de 2026

Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source

Source document· April 20, 2026

Crypto News: Pepeto Presale Demand Update as Bitcoin Price Prediction Targets $250,000

View original at globenewswire.com

Crypto News: Pepeto Presale Demand Update as Bitcoin Price Prediction Targets $250,000 Dubai, UAE, April 19, 2026 (GLOBE NEWSWIRE) -- Pepeto dominates this week crypto news, where the team confirmed that presale demand hit its highest monthly pace yet with token entries growing every day as the project nears launch…

Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

Bitcoin price will reach $250,000
60% confidence
Bitcoin price base target is $150,000
60% confidence
A clean break above $76,000 opens the path toward $85,000 for Bitcoin
60% confidence
Bitcoin price will reach $250,000
60% confidence
Presale demand hit its highest monthly pace yet with token entries growing every day
60% confidence
Bitcoin price will go above $200,000
60% confidence
Bitcoin will set a new all-time high this year
60% confidence
Total crypto market cap is expected to cross $10 trillion this year
60% confidence

Data points we hold from this source

Bitcoin · price

75000 USD

Lo que sabemos · la inteligencia detrás de esta página

En vivo desde el sustrato

Lo que estamos viendo

Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic

Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.

Nuestra lectura de los datos ›

Señales que seguimos

EPKINLY Regulatory-Clinical Success Cascade

High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.

Patrones que observamos ›

Donde las fuentes discrepan

Ford Motor Company

Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.

Señalamos los conflictos abiertamente ›

Verificado recientemente

✓ Verificado con la fuente original

4,995

hechos rastreados a su fuente — y señalamos los que no se sostienen.

101 entidades seguidas4,995 hechos verificados con la fuente5,577 documentos fuente archivados

Consulta estos datos → isubstrate.com

Crypto News: Pepeto Presale Demand Update as Bitcoin Price Prediction Targets $250,000 — Source | Via News | es.VIA.NEWS